vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and YORK WATER CO (YORW). Click either name above to swap in a different company.
YORK WATER CO is the larger business by last-quarter revenue ($19.4M vs $13.8M, roughly 1.4× Gossamer Bio, Inc.). YORK WATER CO runs the higher net margin — 26.7% vs -342.3%, a 369.0% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 3.2%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
The York Water Company is an investor-owned, public utility company based in York, Pennsylvania and operating throughout Pennsylvania. The company was founded in 1816 by a group of local businessmen concerned about fire protection.
GOSS vs YORW — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $19.4M |
| Net Profit | $-47.2M | $5.2M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 33.2% |
| Net Margin | -342.3% | 26.7% |
| Revenue YoY | 47.1% | 3.2% |
| Net Profit YoY | -43.0% | 0.5% |
| EPS (diluted) | $-0.21 | $0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $19.4M | ||
| Q3 25 | $13.3M | $20.2M | ||
| Q2 25 | — | $19.1M | ||
| Q1 25 | — | $18.3M | ||
| Q4 24 | — | $18.8M | ||
| Q3 24 | — | $19.6M | ||
| Q2 24 | $95.8M | $18.6M | ||
| Q1 24 | $0 | $17.5M |
| Q4 25 | $-47.2M | $5.2M | ||
| Q3 25 | $-48.2M | $6.2M | ||
| Q2 25 | — | $5.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | — | $5.9M | ||
| Q2 24 | $49.2M | $5.0M | ||
| Q1 24 | $-41.9M | $4.3M |
| Q4 25 | -333.6% | 33.2% | ||
| Q3 25 | -369.4% | 39.1% | ||
| Q2 25 | — | 37.1% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | 35.8% | ||
| Q3 24 | — | 41.1% | ||
| Q2 24 | 54.3% | 37.9% | ||
| Q1 24 | — | 35.5% |
| Q4 25 | -342.3% | 26.7% | ||
| Q3 25 | -362.7% | 30.6% | ||
| Q2 25 | — | 26.5% | ||
| Q1 25 | — | 19.8% | ||
| Q4 24 | — | 27.4% | ||
| Q3 24 | — | 29.9% | ||
| Q2 24 | 51.4% | 26.8% | ||
| Q1 24 | — | 24.7% |
| Q4 25 | $-0.21 | $0.36 | ||
| Q3 25 | $-0.21 | $0.43 | ||
| Q2 25 | — | $0.35 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $0.36 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | $0.22 | $0.35 | ||
| Q1 24 | $-0.19 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $1.0K |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-122.8M | $240.3M |
| Total Assets | $172.2M | $680.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $1.0K | ||
| Q3 25 | $180.2M | $1.0K | ||
| Q2 25 | — | $1.0K | ||
| Q1 25 | — | $1.0K | ||
| Q4 24 | — | $1.0K | ||
| Q3 24 | — | $1.0K | ||
| Q2 24 | $354.5M | $1.0K | ||
| Q1 24 | $244.4M | $3.3M |
| Q4 25 | $-122.8M | $240.3M | ||
| Q3 25 | $-82.3M | $238.0M | ||
| Q2 25 | — | $234.6M | ||
| Q1 25 | — | $232.1M | ||
| Q4 24 | — | $231.2M | ||
| Q3 24 | — | $228.7M | ||
| Q2 24 | $81.5M | $225.4M | ||
| Q1 24 | $26.7M | $222.9M |
| Q4 25 | $172.2M | $680.9M | ||
| Q3 25 | $208.8M | $667.1M | ||
| Q2 25 | — | $653.7M | ||
| Q1 25 | — | $641.8M | ||
| Q4 24 | — | $633.5M | ||
| Q3 24 | — | $621.4M | ||
| Q2 24 | $373.4M | $610.4M | ||
| Q1 24 | $259.4M | $602.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $8.4M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | 1.63× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $8.4M | ||
| Q3 25 | $-36.2M | $7.8M | ||
| Q2 25 | — | $7.6M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $10.2M | ||
| Q3 24 | — | $7.5M | ||
| Q2 24 | $116.3M | $6.7M | ||
| Q1 24 | $-52.3M | $6.1M |
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 1.63× | ||
| Q3 25 | — | 1.26× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.98× | ||
| Q3 24 | — | 1.29× | ||
| Q2 24 | 2.36× | 1.34× | ||
| Q1 24 | — | 1.42× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
